Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Xolair 75 mg" (12)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Omalizumab (R03DX05) 12 products
WHO-DDD
DrugBank.ca
L
IP
CI
Xolair 75 mg/0.5 ml
187.92
220.80
10 %
Injection solution in prefilled syringe: Omalizumabum 75mg / 0.5ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Xolair 150 mg/1.0 ml
375.83
425.15
10 %
Injection solution in prefilled syringe: Omalizumabum 150mg / 1ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
Xolair 300 mg/2 ml
751.66
833.90
10 %
Injection solution in prefilled syringe: Omalizumabum 300mg / 2ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
Xolair 150 mg/1.0 ml
375.83
425.15
10 %
Injektionslösung in einem Fertigpen: Omalizumabum 150 mg/ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
Xolair 300 mg/2.0 ml
751.66
833.90
10 %
Injektionslösung in einem Fertigpen: Omalizumabum 300mg / 2ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Xolair 75 mg/0.5 ml
PR
PR
k.A.
Injektionslösung in einem Fertigpen: Omalizumabum 75mg / 0.5ml
Novartis Pharma
Schweiz AG
B
FB
G
Omlyclo 75 mg/0.5 ml
PR
PR
k.A.
solution injectable en seringue préremplie: Omalizumabum 75mg / 0.5ml
iQone Healthcare
Switzerland SA
B
FB
G
Omlyclo 150 mg/1 ml
PR
PR
k.A.
solution injectable en seringue préremplie: Omalizumabum 150 mg/ml
iQone Healthcare
Switzerland SA
B
FB
G
L
IP
CI
Xolair 75 mg/0.5 ml
187.92
220.80
10 %
Injection solution in prefilled syringe: Omalizumabum 75mg / 0.5ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Xolair 150 mg/1.0 ml
375.83
425.15
10 %
Injection solution in prefilled syringe: Omalizumabum 150mg / 1ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
SIP
IP
CI
Xolair 150 mg
ampoule(s)
375.83
425.15
10 %
Lyophilisate and solvent: Omalizumabum 150 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
SIP
IP
CI
Xolair 75 mg
ampoule(s)
PR
PR
k.A.
Lyophilisate and solvent: Omalizumabum 75 mg
Novartis Pharma
Schweiz AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
